Acuerdo Marco para el Suministro de Medicamentos sin competencia para los Hospitales del Servicio Cántabro de Salud (Principios activos Blinatumomab, Carfilzomib, Sotorasib, Romiplostim, Etelcalcetida hidrocloruro, Evolocumab, Inebilizumab, panitumumab)

01

Description

02

2 open tenders right now

• Works contract for the construction of an endoscopy unit at the Marques de Valdecilla University Hospital 9 Oct 2026 · 12 days left
• Health services - Framework agreement for diagnostic imaging tests (radiology, MRI and ultrasound) for the Cantabrian Health Service 21 Oct 2026 · 24 days left

Recent awards

• Productos farmacéuticos - Acuerdo Marco para el suministro de medicamentos exclusivos para el Hospital Universitario Marqués de Valdecilla.

  awarded to GILEAD SCIENCES, S.L.; NOVARTIS FARMACEUTICA, S.A.; BRISTOL MYERS SQUIBB, S.A.U; JANSSEN CILAG, S.A.; VERTEX PHARMACEUTICALS SPAIN, S.L.

• Pharmaceutical products - Framework agreement for the supply of medicines without competition for hospitals of the Cantabrian Health Service

  awarded to AMGEN S.A.

• Pharmaceutical products - Framework agreement for the supply of medicines without competition for hospitals of the Cantabrian Health Service (active ingredients Luspatercept, Mavacamten, Fedratinib, Belatacept, Abatacept, Deucravacitinib, Ipilimumab, Ozanimod)

  awarded to BRISTOL-MYERS SQUIBB, S.A.

04

Market context

Avg. open tender · Medical equipment & pharmaceuticals

€10,101,350

9,621 open across Europe right now 64% above sector average

Buyer track record on Aperlena

448 notices tracked · 417 awarded

€56,500,764 in awarded contracts